全球睫状肌麻痹剂市场，按作用机制（阿托品、环戊托酯、环丙沙星、去氧肾上腺素）、根源（口服、外用）、适应症（弱视治疗、肺结核姑息治疗、葡萄膜炎）、分销渠道（医院、在线、零售）划分——行业趋势及预测至 2029 年。
环麻痹剂市场分析及规模
环戊醇酯是一种常见的睫状肌麻痹剂，其作用在 20 至 45 分钟内达到峰值，残留效应可持续长达 36 小时（Cooper 等人，2000 年）。轻度胃肠道不适和喂养不耐受是最常见的副作用，但也有报道称，该药还会出现更严重的阿托品样毒性，症状包括呕吐、肠梗阻、高热、谵妄和癫痫大发作。
Data Bridge Market Research 分析称，睫状肌麻痹剂市场预计在 2022 年至 2029 年的预测期内将达到健康的复合年增长率。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
环麻痹剂市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
作用机制（阿托品、环戊托酯、环丙沙星、去氧肾上腺素）、根源（口服、外用）、适应症（弱视治疗、肺结核姑息治疗、葡萄膜炎）、分销渠道（医院、线上、零售） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
辉瑞公司（美国）、Henry Schein 公司（美国）、Actiza Pharmaceutical Private Limited（印度）、hameln pharma gmbh（德国）、Sigma Pharmaceuticals, LLC（美国）、Biomedica（印度）、Prudence Pharma Chem（印度）、Heer Pharma Pvt. Ltd.（印度）、Fresenius Kabi AG（德国） |
|
市场机会 |
|
市场定义
Cycloplegic agents act by paralysing the iris's sphincter muscle, causing dilation, and by paralysing the ciliary muscle, which inhibits accommodation. Atropine, homatropine, scopolamine, cyclopentolate, and tropicamide are examples of cycloplegic agents. Preventing movement of the iris or ciliary body's dilator and sphincter muscles with cycloplegic drugs often relieves pain in inflammatory conditions such as uveitis and is a standard therapeutic procedure. Furthermore, as a result of the local release of prostaglandins, the iris usually constricts during irritation or inflammation. This makes it easier for adhesions to form with the lens. Cycloplegics also aid in the prevention of this complication.
Global Cycloplegic Agents Market Dynamics
Drivers
- Increasing cases of uveitis
Pediatric uveitis, which accounts for approximately 10-15% of all uveitis cases, presents unique diagnostic, follow-up, and treatment challenges. The insidious nature of uveitis in childhood, as well as paediatric patients' inability to adequately express their complaints and cooperate with eye examination, can cause a delay in diagnosis. More importantly, paediatric uveitis is more severe and often chronic. All these factors increase the likelihood of complications leading to vision loss. As a result, patients with refractory uveitis require paediatric rheumatology follow-up to begin systemic treatment and to detect underlying rheumatologic disease. These are the certain factors which propel the growth of the market.
- Rising Demand for Drugs
Three of the new parasympathomimetic-blocking agents appear to be effective cycloplegic drugs appropriate for refraction. These are disubstituted acetic acid esters (Treves and Testa, Ehrenberg, Ramp, Blanchard, and Treves). These drugs have been identified as cyclopentolate (Compound 75 GT), cyclopentolate (Compound 92 GT), and cyclopentolate (Compound 93 GT). Their use in 0.5% solution has previously been reported (cyclopentolate, by Priestley and Medine, and all three compounds by Gettes and Leopold and by Stolzer). Their cycloplegic efficiency appeared to be higher than homatropine but not quite as high as atropine. Furthermore, they have the benefit of a shorter duration of activity and the absence of local or systemic reactions.
Opportunities
- Rising usage of cycloplegic drugs
Cycloplegic drugs are muscarinic receptor blockers. Atropine, cyclopentolate, homatropine, scopolamine and tropicamide are among them. They are approved for use in cycloplegic refraction (paralysing the ciliary muscle to determine the true refractive error of the eye) and uveitis treatment. These are the factors which is expected to grow of the market.
Restraints/Challenges
- High cost of cycloplegic agents
睫状肌麻痹剂的高成本以及新兴和欠发达国家的低采用率将阻碍市场的增长速度。睫状肌麻痹的主要缺点是患者会出现视力模糊和畏光的暂时症状。由于瞳孔散大，调节反应消失和眼部像差增加会导致视力下降。
本睫状肌麻痹剂市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关睫状肌麻痹剂市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球睫状肌麻痹剂市场范围
睫状肌麻痹剂市场根据作用机制、根源、适应症和分销渠道进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
作用机制
- 阿托品
- 环戊醇酯
- 环丙沙星
- 苯肾上腺素
根
- 口服
- 主题
指征
- 弱视治疗
- 肺结核的姑息治疗
- 葡萄膜炎
分销渠道
- 医院
- 在线的
- 零售
环麻痹剂市场区域分析/见解
对睫状肌麻痹剂市场进行了分析，并按国家、作用机制、根源、适应症和分销渠道提供了市场规模见解和趋势，如上所述。
睫状肌麻痹剂市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美拥有完善的医疗保健基础设施和优惠的报销政策，因此在睫状肌麻痹剂市场占据主导地位。
由于葡萄膜炎病例的增加，预计亚太地区在 2022 年至 2029 年的预测期内将以最高的增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
睫状肌麻痹剂市场还为您提供了详细的市场分析，包括每个国家/地区资本设备医疗支出的增长、睫状肌麻痹剂市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗监管情景的变化及其对睫状肌麻痹剂市场的影响。数据涵盖 2010-2020 年的历史时期。
竞争格局和环麻痹剂市场份额分析
睫状肌麻痹剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对睫状肌麻痹剂市场的关注有关。
睫状肌麻痹剂市场的一些主要参与者包括：
- 辉瑞公司（美国）
- Henry Schein, Inc（美国）
- Actiza Pharmaceutical Private Limited（印度）
- hameln pharma gmbh（德国）
- Sigma Pharmaceuticals, LLC（美国）
- 生物医药（印度）
- Prudence Pharma Chem（印度）
- Heer Pharma Pvt. Ltd.（印度）
- 费森尤斯卡比公司（德国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
